This article examines the challenges healthcare professionals face when addressing the
modern and often twin epidemics of frailty and diabetes mellitus (DM) in ageing societies …

Sarcopenia is an age-related clinical complaint characterized by the progressive
deterioration of skeletal muscle mass and strength over time. Type 2 diabetes (T2D) is …

Muscle loss is an important feature that occurs in multiple pathologies including
osteoarthritis (OA), chronic obstructive pulmonary disease (COPD) and type II diabetes …

Today, type 2 diabetes mellitus (T2DM) and skeletal muscle atrophy (SMA) have become
increasingly common occurrences. Whether the onset of T2DM increases the risk of SMA or …

Sarcopenia remains one of the major pathological features of type 2 diabetes (T2D),
especially in older individuals. This condition describes gradual loss of muscle mass …

Sarcopenia is characterized by progressive loss of muscle mass and function, and it is
becoming a serious public health problem with the aging population. However, a …

Type 2 diabetes mellitus (T2DM) and sarcopenia (low skeletal muscle mass and function)
share a bidirectional relationship. The prevalence of these diseases increases with age and …

Background Sarcopenia is characterized by the age-associated loss of skeletal muscle
mass and strength that develops progressively and plays an important role in the disability of …

Significant loss of muscle mass may occur in cachexia and sarcopenia, which are major
causes of mortality and disability. Cachexia represents a complex multi-organ syndrome …

Obesity and type 2 diabetes mellitus (T2DM) are widespread, non-communicable diseases
that are responsible for considerable levels of morbidity and mortality globally, primarily in …